Key points are not available for this paper at this time.
We provide evidence that there is a significant decrease in CSF-OP in patients with idiopathic intracranial hypertension 3 months after VSS, independent of acetazolamide usage or weight loss.
Patsalides et al. (Tue,) studied this question.